glp 1 and kidneys GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 receptor agonists show promise

More reported that they had stopped taking the drugs due to difficulty affording them (14%) than reported they had stopped due to side effects (13%)

Pain Med 2006;7(Suppl 1):S14-26.Article 100

GLP-1 BENEFITS Do more, age less GLP-1s mimics glucagon-like peptide (GLP-1), a hormone that regulates appetite and food intake

The strongest support comes from clinical evidence focused on treating vitamin B12 deficiency, not from general wellness claims What science supports The NIH Fact Sheet for Health Professionals shows that intramuscular B12 injections are effective at raising blood B12 levels and correcting deficiency

Balaban, N